InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Revolution Medicines, Inc.

RVMD Clue Score22
United States Fiscal year ends December CIK 0001628171
$189.76 +0.87% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $189.76 +584.07% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 13 Feb 2020. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2018Revenue20.2Operating income−40.3Net income−41.8Fiscal year 2019Revenue50.0 +148.2%Operating income−54.1Net income−47.7Fiscal year 2020Revenue43.0 −14.1%Operating income−110.7Net income−108.2EPS, diluted−2.01Fiscal year 2021Revenue29.4 −31.6%Operating income−188.0Net income−187.1EPS, diluted−2.57Fiscal year 2022Revenue35.4 +20.4%Operating income−258.3Net income−248.7EPS, diluted−3.08Fiscal year 2023Revenue11.6 −67.3%Operating income−487.2Net income−436.4EPS, diluted−3.86Fiscal year 2024Revenue0.0 −100.0%Operating income−689.5Net income−600.1EPS, diluted−3.58Fiscal year 2025Revenue0.0Operating income−1,182.4Net income−1,131.3EPS, diluted−5.95
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 20.2 50.0 43.0 29.4 35.4 11.6 0.0 0.0
Growth +148.2% −14.1% −31.6% +20.4% −67.3% −100.0%
Operating income −40.3 −54.1 −110.7 −188.0 −258.3 −487.2 −689.5 −1,182.4
Net income −41.8 −47.7 −108.2 −187.1 −248.7 −436.4 −600.1 −1,131.3
Growth
EPS, diluted n/a n/a −2.01 −2.57 −3.08 −3.86 −3.58 −5.95
Growth

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2018Operating margin−200.0%Net margin−207.2%Free cash flow margin−1.4%Fiscal year 2019Operating margin−108.2%Net margin−95.2%Free cash flow margin−104.3%Fiscal year 2020Operating margin−257.5%Net margin−251.6%Free cash flow margin−239.6%Fiscal year 2021Operating margin−639.7%Net margin−636.6%Free cash flow margin−523.0%Fiscal year 2022Operating margin−730.0%Net margin−703.0%Free cash flow margin−664.8%Fiscal year 2023Operating margin−4,207.1%Net margin−3,768.3%Free cash flow margin−3,094.1%Fiscal year 2024Fiscal year 2025
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin −200.0% −108.2% −257.5% −639.7% −730.0% −4,207.1% n/a n/a
Net margin −207.2% −95.2% −251.6% −636.6% −703.0% −3,768.3% n/a n/a
Free cash flow margin −1.4% −104.3% −239.6% −523.0% −664.8% −3,094.1% n/a n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2018Operating cash flow1.2Capital expenditure−1.5Free cash flow−0.3Fiscal year 2019Operating cash flow−49.6Capital expenditure−2.6Free cash flow−52.2Fiscal year 2020Operating cash flow−100.1Capital expenditure−2.9Free cash flow−103.0Dividends paid0.0Fiscal year 2021Operating cash flow−147.2Capital expenditure−6.5Free cash flow−153.7Fiscal year 2022Operating cash flow−224.4Capital expenditure−10.8Free cash flow−235.2Fiscal year 2023Operating cash flow−350.6Capital expenditure−7.7Free cash flow−358.3Fiscal year 2024Operating cash flow−557.4Capital expenditure−10.3Free cash flow−567.7Fiscal year 2025Operating cash flow−897.7Capital expenditure−16.0Free cash flow−913.7
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow 1.2 −49.6 −100.1 −147.2 −224.4 −350.6 −557.4 −897.7
Capital expenditure −1.5 −2.6 −2.9 −6.5 −10.8 −7.7 −10.3 −16.0
Free cash flow −0.3 −52.2 −103.0 −153.7 −235.2 −358.3 −567.7 −913.7
Growth
Dividends paid n/a n/a 0.0 n/a n/a n/a n/a n/a

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2018Cash69.6Shareholders’ equity−108.4Fiscal year 2019Cash16.7Shareholders’ equity−152.6Fiscal year 2020Cash104.3Shareholders’ equity474.7Fiscal year 2021Cash108.5Shareholders’ equity602.6Fiscal year 2022Cash161.4Shareholders’ equity685.2Fiscal year 2023Cash696.1Shareholders’ equity1,826.2Fiscal year 2024Cash543.1Shareholders’ equity2,265.2Fiscal year 2025Cash383.7Shareholders’ equity1,631.3
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 69.6 16.7 104.3 108.5 161.4 696.1 543.1 383.7
Shareholders’ equity −108.4 −152.6 474.7 602.6 685.2 1,826.2 2,265.2 1,631.3

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Cash flow

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Operations
1.2 −49.6 −100.1 −147.2 −224.4 −350.6 −557.4 −897.7
Growth −4,190.4%
1.6 2.3 2.6 3.1 4.0 5.0 6.6 7.8
Investment
−1.5 −2.6 −2.9 −6.5 −10.8 −7.7 −10.3 −16.0
calc −0.3 −52.2 −103.0 −153.7 −235.2 −358.3 −567.7 −913.7
Growth
calc n/a n/a −1.88 −2.11 −2.92 −3.17 −3.38 −4.81
−1.3 −102.0 −234.2 −142.1 −24.1 −342.6 −554.4 118.1
Financing
60.8 98.7 422.8 294.2 301.4 1,229.2 959.4 621.5
n/a n/a 0.0 n/a n/a n/a n/a n/a

Lines marked calc are worked out here from filed figures; point at one for how. Capital expenditure, dividends and buybacks are shown as money out, so negative.